Approval Probability
TA Base Rate
Adjusted LOA
ML Risk
Also known as Octenidine Dihydrocloride in aqueous solution
Octenidine Dihydrocloride in aqueous · 1 trial · 1 indication
| Arm | Type | Description |
|---|---|---|
| Investigational Product | EXPERIMENTAL | Polyester cloth impregnated with investigational product |
| Vehicle Control (VC) | PLACEBO_COMPARATOR | Polyester cloth impregnated with the vehicle control |
| Saline Control (SC) | PLACEBO_COMPARATOR | Saline applied wtih polyester cloth |
| Name | Type | Description |
|---|---|---|
| Octenidine Dihydrocloride in aqueous solution | DRUG | application of investigational product |
| Vehicle Control | OTHER | application of vehicle control |
| Saline Control | OTHER | application of placebo |
Inclusion Criteria: * Males and/or females, at least 18 years or older and of any race. * Are in good general health. * Unable to become pregnant, or willing to use an acceptable method of contraception (i.e. oral contraception, intra-uterine device \[IUD\], diaphragm, condom, abstinence, bilateral...
Octenidine dihydrochloride in aqueous solution is being developed for preoperative skin preparation, a dermatology use in which skin is treated before surgery to reduce microorganisms at the surgical site. Becton, Dickinson and Company is developing it, and the program has reached Phase 2 clinical development.
Becton, Dickinson and Company, which trades under the ticker BDX, is the developer of octenidine dihydrochloride in aqueous solution. The company has studied the agent in a Phase 2 trial in preoperative skin preparation, and the program remains in clinical development.
Octenidine dihydrochloride in aqueous solution is in Phase 2 development. One Phase 2 trial has been completed, and no trials are currently active. The agent is investigational and is not an approved product for preoperative skin preparation.
Octenidine dihydrochloride in aqueous solution has been evaluated in the Phase 2 trial NCT03229759, titled Evaluation of the Antimicrobial Effectiveness of an Antimicrobial Cloth. That completed trial enrolled 99 participants in the United States, included adults 18 years and older of all sexes, and accepted healthy volunteers.
The Phase 2 trial NCT03229759 was a randomized, double-blind, placebo-controlled study of octenidine dihydrochloride in aqueous solution for preoperative skin preparation. It enrolled 99 participants and has been completed. The study took place in the United States and enrolled healthy volunteers aged 18 years and older.
Yes, octenidine dihydrochloride in aqueous and octenidine dihydrochloride in aqueous solution refer to the same investigational product from Becton, Dickinson and Company. Both names describe the aqueous formulation studied in Phase 2 for preoperative skin preparation under trial NCT03229759.